Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media › C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629)
02/2012
02/16/2012US20120042417 Enhanced accumulation of carotenoids in plants
02/16/2012US20120042416 Antibody fusion-mediated plant resistance against Oomycota
02/16/2012US20120042413 Compositions And Methods Comprising Sequences Having Hydroxyphenylpyruvate Dioxygenase (HPPD) Activity
02/16/2012US20120042412 Methods And Compositions For Targeting Sequences Of Interest To The Chloroplast
02/16/2012US20120042411 Gene targeting in plants
02/16/2012US20120042410 Abscisic acid carrier gene and transgenic plant expressing the same
02/16/2012US20120042409 Plant transformation using dna minicircles
02/16/2012US20120042407 Corn event 5307
02/16/2012US20120042404 Pepper hybrid ps 11446271
02/16/2012US20120042400 Rtd receptor
02/16/2012US20120042399 Immunogenic peptides
02/16/2012US20120041218 Synthesis of long-chain polyunsaturated fatty acids by recombinant cells
02/16/2012US20120041176 Ucp4
02/16/2012US20120041070 Methods of treating cancer having an aberrant egfr or kras genotype
02/16/2012US20120041055 Composite polynucleic acid therapeutics
02/16/2012US20120041054 Compositions and methods for the treatment of sepsis and other disorders involving phospholipase a2 induction
02/16/2012US20120041052 Compositions and Methods to Treat Muscular & Cardiovascular Disorders
02/16/2012US20120041051 Compositions And Methods For Inhibiting Expression Of MIG-12 Gene
02/16/2012US20120041049 Design of small-interfering rna
02/16/2012US20120041039 Amine derivative compounds for treating ophthalmic diseases and disorders
02/16/2012US20120041038 Amine derivative compounds for treating ophthalmic diseases and disorders
02/16/2012US20120040995 Design, synthesis and evaluation of procaspase activating compounds as personalized anti-cancer drugs
02/16/2012US20120040985 Triazole and imidazole derivatives for use as tgr5 agonists in the treatment of diabetes and obesity
02/16/2012US20120040971 Benzodiazepinone compounds useful in the treatment of skin conditions
02/16/2012US20120040961 Pyrimido-diazepinone kinase scaffold compounds and methods of treating disorders
02/16/2012US20120040937 Compounds for the treatment of proliferative disorders
02/16/2012US20120040935 Compositions useful as inhibitors of voltage-gated ion channels
02/16/2012US20120040918 Peptide nucleic acid derivatives with good cell penetration and strong affinity for nucleic acid
02/16/2012US20120040917 Splice Switching Oligomers for TNF Superfamily Receptors and Their Use in Treatment of Disease
02/16/2012US20120040900 Compositions of and methods of using ligand dimers
02/16/2012US20120040894 Mini-Hepcidin Peptides and Methods of Using thereof
02/16/2012US20120040891 Hiv fusion inhibitor peptides with improved biological properties
02/16/2012US20120040464 Method for generating homoplasmic cells from heteroplasmic cells
02/16/2012US20120040463 Hollow, notably multi-membrane fibers, method for preparation thereof by spinning and device for applying said method
02/16/2012US20120040461 Fabrication of nanofiber reinforced structures for tissue engineering
02/16/2012US20120040460 Ribonucleic Acid Interference Molecules
02/16/2012US20120040459 Reduced size self-delivering rnai compounds
02/16/2012US20120040458 Method for producing dendritic cells
02/16/2012US20120040457 Small molecules that replace or agonize p53 function
02/16/2012US20120040456 Methods of gene therapy using nucleic acid sequences for atp-binding cassette transporter
02/16/2012US20120040455 Curved polyhedrons
02/16/2012US20120040454 Process for producing a human t-cell population having both cytotoxic and immunosuppressive activities
02/16/2012US20120040453 Bioreactor using oxygen-carrying molecules
02/16/2012US20120040452 Glypican-3 (gpc3)-derived tumor rejection antigenic peptides useful for hla-a2-positive patients and pharmaceutical comprising the same
02/16/2012US20120040438 Novel Porcine Circovirus Type 2B Isolate and Uses Thereof
02/16/2012US20120040435 Novel Variant Hypocrea Jecorina CBH2 Cellulases
02/16/2012US20120040417 Hydroxynitrile lyase
02/16/2012US20120040410 Thermohemicellulases for lignocellulosic degradation
02/16/2012US20120040402 Plasmid system for multigene expression
02/16/2012US20120040401 Method For Producing Proteins
02/16/2012US20120040400 Novel Permanent Human Cell Line
02/16/2012US20120040399 Method for the production of recombinant polyomaviral vector particles
02/16/2012US20120040398 Engineered cleavage half-domains
02/16/2012US20120040394 Microtumours
02/16/2012US20120040393 Directed Differentiation of Primate Pluripotent Stem Cells Into Functional Basal Forebrain Cholinergic Neurons (BFCNs) and Medium Spiny Gabaergic Projection Neurons
02/16/2012US20120040390 Method for Introducing Protein and/or Peptide Into Cell
02/16/2012US20120040368 Mutated voltage-gated sodium channel nav alpha subunit for identification of modulators
02/16/2012US20120040362 Multipotent Lymphohematopoietic Progenitor Cells
02/16/2012US20120040024 Methods and compositions for enhancing survivability of cells, tissues, organs and organisms
02/16/2012US20120040021 Methods and compositions for the treatment of cancer
02/16/2012US20120039984 Glycopeptide and uses thereof
02/16/2012US20120039961 Implant and therapeutic composition for treating damage and/or diseases relating to the human animal musculoskeletal system
02/16/2012US20120039936 Intergenic regions as insertion sites in the genome of modified vaccinia virus ankara (mva)
02/16/2012US20120039929 Novel therapy for lysosomal enzyme deficiencies
02/16/2012US20120039926 Compositions and Methods for Modulating Immunogenic Responses by Activating Dendritic Cells
02/16/2012US20120039923 Modified HIV-1 Envelope Proteins
02/16/2012US20120039921 Poultry viral materials and methods related thereto
02/16/2012US20120039919 Diabetes diagnostic, prophylactic, and therapeutic compositions and methods
02/16/2012US20120039918 Composition for Enhancing Immunity Containing Plant Stem Cell Line Derived from Cambium of Panax Ginseng Including Wild Ginseng or Ginseng as an Active Ingredient
02/16/2012US20120039917 Immunomodulating activities
02/16/2012US20120039916 Novel vaccine adjuvants based on targeting adjuvants to antibodies directly to antigen-presenting cells
02/16/2012US20120039915 Glioblastoma multiforme-reactive antibodies and methods of use thereof
02/16/2012US20120039914 Methods and compositions for using mhc class ii invariant chain polypeptides as a receptor for macrophage migration inhibitory factor
02/16/2012US20120039908 Control of Protein Glycosylation and Compositions and Methods Relating Thereto
02/16/2012US20120039907 Polypeptides including modified constant regions
02/16/2012US20120039906 PD-1 Antibodies and PD-L1 Antibodies and Uses Thereof
02/16/2012US20120039905 The Role of p110 delta Signaling in Morbidity and Lung Pathology Induced by Influenza Virus Infection
02/16/2012US20120039904 Anti system asc amino acid transporter 2 (asct2) antibody
02/16/2012US20120039898 Human binding molecules capable of neutralizing influenza virus h3n2 and uses thereof
02/16/2012US20120039889 Methods of diagnosing and treating prostate cancer characterized by ndrg1-erg fusion
02/16/2012US20120039880 FRAGMENTATION RESISTANT IgG1 Fc-CONJUGATES
02/16/2012US20120039878 Treatment and prophylaxis of amyloidosis
02/16/2012US20120039874 Human monoclonal antibody against a costimulatory signal transduction molecule ailim and pharmaceutical use thereof
02/16/2012US20120039870 Binding molecules with multiple binding sites, compositions comprising the same and uses thereof
02/16/2012US20120039869 Methods of using molecular conjugates comprising monoclonal antibodies to dendritic cells
02/16/2012US20120039867 Immune System Function in Conditions Characterized by Elevated Double Strand Breaks
02/16/2012US20120039865 Identification of sortilin as a neuronal receptor for the frontotemporal dementia protein, progranulin
02/16/2012US20120039858 Methods and compositions for inhibiting propagation of viruses using recombinant tetherin constructs
02/16/2012US20120039851 Use of androgens for vascular regeneration and endothelial repair
02/16/2012US20120039847 Hepatitis C Virus Inhibitors
02/16/2012US20120039846 Hepatitis c antibodies and uses thereof
02/16/2012US20120039841 T-Helper Cell Type 17 Lineage-Specific Adjuvants, Compositions and Methods
02/16/2012US20120039810 Aptamer-containing compositions and methods for targeting e-selectin
02/16/2012US20120039807 Anti-Tenascin-C A2 Antibodies and Methods of Use
02/16/2012US20120039806 Compounds and Methods for Modulating an Immune Response
02/16/2012US20120039798 Methods of modifying p53 acetylation and treating cancer using avra
02/16/2012DE102010034331A1 Polymer-gestützte Kultursysteme Polymer-based culture systems
02/16/2012DE102010034330A1 Verfahren zur Herstellung desinfizierter humaner Zellsuspensionen Process for the preparation of disinfected human cell suspensions
02/16/2012CA2807935A1 Method of producing pancreatic hormone-producing cells
02/16/2012CA2807892A1 Compositions and methods for producing dendritic cells
1 ... 273 274 275 276 277 278 279 280 281 282 283 284 285 286 287 288 289 290 291 292 293 ... 1827